According to Glenmark Life Sciences latest financial reports the company has an operating margin of 0.29%, an increase of 5.78% to 2022. At the end of 2022 company had an operating margin of 0.28%.
Year | Operating Margin | Change |
---|---|---|
2023 | 0.29% | 5.78% |
2022 | 0.28% | -8.10% |
2021 | 0.30% | 1.61% |
2020 | 0.30% | - |